Laila Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 39.00 Cr
as on 14-12-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets %
(FY 2023)
About Laila Nutraceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹39.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Venkata Gokaraju and Gokaraju Devi serve as directors at the Company.
- CIN/LLPIN
U85110AP2006PTC049776
- Company No.
049776
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- LocationVijayawada- 520 010.A.P., Andhra Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Laila Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Gokaraju  | Director | 10-Apr-2006 | Current |
| Gokaraju Devi | Director | 10-Aug-2014 | Current |
Financial Performance of Laila Nutraceuticals.
Laila Nutraceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Laila Nutraceuticals?
Unlock access to Laila Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Chemiloids Life Sciences Private LimitedActive 10 years 4 monthsVenkata Gokaraju is a mutual person
- Sri Hanumath Kali Varaprasada Babu Chemicals Private Limited.Active 47 years 9 months
Venkata Gokaraju is a mutual person
- Sri Satyadev Carbondioxide Private LimitedActive 25 years 5 months
Venkata Gokaraju is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tamilnad Mercantile Bank Limited Creation Date: 31 May 2013 | ₹39.00 Cr | Satisfied |
How Many Employees Work at Laila Nutraceuticals?
Unlock and access historical data on people associated with Laila Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Laila Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laila Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
